土拉弗朗西斯菌
土拉热病
弗朗西塞拉
细胞内寄生虫
微生物学
病菌
细胞内
抗生素
生物
病毒学
毒力
遗传学
基因
作者
Shannon Whiles,Quan-Zheng Zhang,Zach Chamberlain,Manish K. Singh,Shaun Steele,Linda Zheng,Kristin L. Rosche,Weigang Huang,Huanyao Gao,Qisheng Zhang,Thomas H. Kawula
出处
期刊:ACS Infectious Diseases
[American Chemical Society]
日期:2024-06-14
卷期号:10 (8): 2775-2784
标识
DOI:10.1021/acsinfecdis.4c00116
摘要
Francisella tularensis is a Gram-negative facultative intracellular bacterial pathogen that is classified by the Centers for Disease Control and Prevention as a Tier 1 Select Agent. F. tularensis infection causes the disease tularemia, also known as rabbit fever. Treatment of tularemia is limited to few effective antibiotics which are associated with high relapse rates, toxicity, and potential emergence of antibiotic-resistant strains. Consequently, new therapeutic options for tularemia are needed. Through screening a focused chemical library and subsequent structure–activity relationship studies, we have discovered a new and potent inhibitor of intracellular growth of Francisella tularensis, D8–03. Importantly, D8–03 effectively reduces bacterial burden in mice infected with F. tularensis. Preliminary mechanistic investigations suggest that D8–03 works through a potentially novel host-dependent mechanism and serves as a promising lead compound for further development.
科研通智能强力驱动
Strongly Powered by AbleSci AI